NCT05274321View on ClinicalTrials.gov

Efficacy of the Nanodropper Device on Pupillary Dilation

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 29, 2021

Primary Completion Date

November 19, 2021

Study Completion Date

November 19, 2021

Conditions
Dilation
Interventions
DEVICE

Nanodropper

Device used for administering eye drops

DEVICE

Standard Eye Dropper

Standard Eye Dropper used for administering eye drops

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

Nanodropper, Inc.

INDUSTRY

lead

University of California, San Francisco

OTHER

NCT05274321 - Efficacy of the Nanodropper Device on Pupillary Dilation | Biotech Hunter | Biotech Hunter